105 results
8-K
LCTX
Lineage Cell Therapeutics Inc
14 Jun 24
Changes in Registrant's Certifying Accountant
5:00pm
, the Audit Committee of the Board of Directors of the Company approved the engagement of Moss Adams LLP (“Moss Adams”) as the Company’s independent
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics Inc
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
of an officer, no officer, agent or employee shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics Inc
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose
8-K
EX-99.1
oit7e5my
11 Aug 22
LINEAGE CELL THERAPEUTICS REPORTs SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:10pm
8-K
EX-10.2
f2yzemj10k6bgmg eo
17 Jun 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
EX-10.1
ec4uia
17 Jun 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
EX-99.1
es0pnkekpf 503d
10 Nov 21
LINEAGE REPORTs THIRD QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS PROGRESS FROM CLINICAL CELL THERAPY PROGRAMS
4:10pm